Rockville biotech continues buying spree with yet another acquisition

Rockville biotech continues buying spree with yet another acquisition

bizjournals

Published

Rockville’s Emmes is sticking to its growth strategy for the past year with its fourth acquisition since a pandemic-era leadership change — and its first so far this year. The contract research organization, which conducts research and clinical trials for public and private sector customers, said Thursday it has purchased Plymouth, Massachusetts-based Casimir LLC, a fellow CRO focused on rare diseases, for an undisclosed amount. The 6-year-old Casimir brings to the table 31 U.S. employees and…

Full Article